Neyrokhirurgia-Grinberg-2010-pdf
.pdf
|
|
|
1. |
90 |
||
|
|
|
|
|
|
|
., Tylox® §) |
|
30 |
|
1 |
2-3 |
|
|
|
|
|
|
|
(Tylox®) |
(OxyContin®) |
|
30-40 |
|
|
12 |
. . 1-24 |
|
|
|
|
|
|
|
|
|
1 |
|
|
3-5 |
|
(Numorphan®) |
PR |
10 |
|
|
|
|
|
|
1,5 |
|
0,5-1 |
3 |
|
(Dilaudid®) |
|
7,5 |
|
1,5-2 |
3 |
1, 2, 3 4 |
|
|
|
|
|
|
|
- |
|
|
|
12-24 |
72 |
, |
|
|
|
|
|
|
25, 50, 75 100 |
(Duragesic®) |
|
|
|
|
|
- |
|
|
|
|
|
|
) |
* 1:6
, 1:2-3
† ,
(Demerol®) ,
15-20
-
( ). -
‡
( 3
, -), . -
,
§ , . 1 Tylox® 5 (
),
OxyContin®
(
)
. 1-26. -,
10 )
|
- |
|
|
|
- |
|
: |
- |
|
) |
|
|
|
( - |
|
|
) |
|
|
|
®) |
|
|
|
|
) |
|
|
|
0,4 |
|
|
|
|
(Buprenex®) |
|
0,3 |
|
|
|
|
|
|
1. |
|
91 |
||
|
|
|
|
|
|
|
* |
|
|||||
|
|
2 |
0,5-1 |
|
4-6 |
|
(Stadol®) |
|
|
|
|
|
|
|
|
10 |
1 |
|
3-6 |
- |
(Nubain®) |
|
140 |
0,5 |
|
2-5 |
- |
|
|
|
|
|
|
† |
|
† |
20-40 |
0,5-14-6 |
|
|
|
(Talwin®‡) |
† |
180 |
1,5-2 |
|
4-7 |
|
Dezocine |
|
10 |
|
|
3-6 |
|
(Dalgan®) |
|
|
|
|
|
|
* , -
†
(Stadol > Nubain), -
‡ Talwin ( ) -
. Talwin® Compound ,
Talwin Nx, ( .
. 1-23, .40)
1.7.1.3.
( , , ).
: -
[ ., (Desyrel®)] -, -
,
. (Elavil®) 75 ,
(Norpramin®) 10-25 , (Sinequan®) 75-150
. , -
.
: , , -
, . , -
, 1,5-2 -
.
6,
.
: . -
, ,
, -
(
1. |
92 |
). (Atarax®, Vistaril®): L: 50
100 . 200 .
: , , , -
, -
, , -
, , -
101.
: -
.
. -(Prolixin®),
( .
, , .528).
.
.
, .
: ,
, .
( . -
, .11).
: ,
65-200 ,
,
.
1.7.2.
(Compazine®, Phenergan® .)
,
(
).
. 1-27. -
, (Zofran®).
-.
. 1-27.
|
|
|
|
1. |
|
|
|
93 |
|||
|
|
|
|
|
||||
|
: 200 |
|
|
|
||||
(Tigan®) |
PR 3-4 ( - |
, - |
||||||
|
) 250 3-4 |
|
(Phenergan®) |
|||||
|
|
|
|
|
|
|
||
|
: ( 10-40 ): 100- |
|
||||||
|
200 3-4 100 |
|
|
|
|
|||
|
PR 3-4 ( |
|
|
|
|
|||
|
|
|
- |
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
: 50 |
- |
|
|
|
|
||
(Dramamine®) |
4 ( 300 ) |
|
|
|
|
|||
|
: 50 |
|
|
|
|
|||
(Benadryl®) |
4 ( 300 ) |
|
|
|
|
|||
|
: 50 |
. - |
||||||
(Bucladin-S®) |
4-6 |
|
|
|
- |
|||
|
|
|
|
|
|
|
. |
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
||
|
: 50 (0,5-1,0 |
|
|
|
|
|||
(Emete-con®) |
) , - |
|
|
|
|
|||
|
, |
- |
|
|
|
|
||
|
3-4 } |
|
|
|
|
|
|
|
|
: |
|
|
|||||
(Reglan ®) |
|
1-2 |
|
- |
||||
|
. |
|
|
|
, |
|||
|
: : 10-15 |
|
- |
|||||
|
4 ; |
|
|
|
(Benadryl®) 50 |
|||
|
: |
( ) |
||||||
|
10 4-6 |
|
|
|
|
|
||
|
(6-14 ): 2,5-5 |
|
|
|
|
|||
|
; |
|
|
|
|
|||
|
(<6 ): 0,1 - |
|
|
|
|
|||
|
|
|
|
|
|
|
||
|
4 2-5 , |
- |
||||||
(Zofran®) |
4 8 , |
|
- |
|||||
|
8 1-2 |
- |
||||||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
1. |
94 |
. ,
,
. -
, , .
(Compazine®)
. 1-28.
. 1-28.
* |
|
: 5-10 3-4 |
<2 <10 |
PR: 25 2 |
PR: 2,5 1-2 |
: 5-10 |
|
HCl (Phenergan®)
L: : 25-50 4-6 . -: 12,5-25 PR .
L: : 0,5 ( 2 6 ) 4-6
. : 6,25-12,5 PR 3 .
(Thorazine®)
L: : 10-25 4-6 -
. : 100 6-8 .
-
; -
.
102 ( . .293).
. -
.
(Flexeril®)
L: : 10 3-4 , 2-3 .
(Robaxin®)
Robaxisal®: 400 + 325 -
.
1. |
95 |
L: :
500 : 3 3 × 48-72 , 1 4 2
3 . 750 : 2 4 × 48-72 , 1
4 2 3 . Robaxisal®:
3 3 , , -
2 4 .
L: : 750 (IVPB)
6-8 .
: 1 10 ; –
500 . Robaxin®-750 750 .
(Parafon Forte® DSC)
(
) -
103.
(Valium®)
L: : 2-10 3-4
. , . .355.
(Soma®)
: ( -
, , -
).
L: : 350 3 .
« ». 70% >65
( , ). -
, ,
. ,
25% 2 4 , -
104. -
( ). :
,
( , ,
, )105.
( . .531).
L: : 200 300
).
1. |
96 |
. , .46. -
-
,
. -
,
( -
, , , , , ,
).
-
106. . -
( . ).
: , ,
. -
I ( -
)100.
. 1-29.
The Medical Letter, 30, .28, 1998)
|
|
|
- |
- |
|
|
|
|
|
|
|
|
|
|
|
Xanax® |
|
|
0,25-0,5 3 |
- |
Librium® |
|
|
5-10 3-4 |
|
|
|
|
|
|
Tranxene® |
|
|
15-60 |
|
|
|
|
|
|
Valium® |
|
|
2-10 2-4 |
|
Ativan® |
|
|
1 2-3 |
|
Paxipam® |
|
|
20-40 3-4 |
|
Centrax® |
|
|
20-60 |
|
|
|
|
|
|
Serax® |
- |
- |
10-15 3-4 |
|
|
|
|
|
|
Dalmane® |
- |
|
30 |
|
|
|
|
|
|
Restoril® |
|
|
15-30 |
(Serax®)
, .
1. |
97 |
L: : 10-15 3-4 ( 30 3-4
-
).
(Xanax®)
-
.
L: : 0,25-0,5 3 , 4 , -
. 0,25, 0,5 1 .
(Versed®)
3-4 (Valim®).
, .
. -
, . -
. 15 ,
30 , 1-2 108.
L:
1., (
): 1-2 2 (
2,5 ), 2-3 ,
0,1-0,15 . -
>60 ,
25%. 25%
. : -
( ).
,
2.: 0,07-0,08 (5 /70 ) 1
3.:
A.( ):
1.55 -
: 0,25
2.>55 : I II ( . -
, .1): 0,2
3.III IV : 0,15
B.: 25% -
:
50 100 ( -
, . -
1. |
98 |
); 1-2
.
(Romazicon®) ( Mazicon®)
-
. . ,
, ,
-
. <2 -
, 6-10 , 1. -
. -
109.
, -
( ),
. -
.
.
L:
, , :
0,2 (2 ) 15 ;
, 1 1 (
5 ). , -
20 , 3
. 0,2 30 , -
30 0,3 ( 30 )
( 3 ).
. : ( .6), (Inderal®) ( .7) -
(Brevibloc®) ( .6).
(Tenormin®)
,
( , ,
)110.
( . .594).
L: ( ): 50 , -
1-2 ; , 100
1. |
99 |
). :
.
: 50 , 100 .
. 1-30 -
111. -
.
. 1-30. |
||||
|
|
|||
|
- |
1 |
|
|
|
|
2 |
|
, - |
|
|
|
|
|
|
|
3 |
|
|
-
- |
4 |
|
|
5 |
|
|
6 |
|
1.7.6.1. ,
(Versed®): . .45
(Nembutal®): . L:
70 : 100
: 25 ( . )
1.7.6.2.
(Pentothal®)
. ( -
) 20-30 ( ), ( -
) 40 , = 5 ( -
), 20-30
.
: , -
, ,